Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
This small pilot randomized placebo‑controlled trial tested a cannabinoid spray (Sativex) in 30 adults with ADHD. The main test of cognition and activity (QbTest) showed no significant difference between Sativex and placebo in the intention‑to‑treat analysis (Estimate = -0.17, 95% CI -0.40 to 0.07, p = 0.16). Some secondary measures…
This was a 6-week, double-blind, placebo-controlled trial that tested low-dose LSD (20 μg) given twice weekly in 53 adults with moderate to severe ADHD. Both the LSD group and the placebo group showed similar symptom reductions by week 6 (LSD mean change on the ADHD rating scale −7.1 points; placebo…
The review found that adults generally felt ADHD medications reduced their ADHD symptoms. But experiences differed a lot because of social, psychological, and physical side effects. People talked about taking medicines in the context of “fitting in” at school, work, and with family and friends. That idea of fitting in…
